Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Europe’s “Nuclear Option” Against Trump Tariffs: Selling US Assets Is Talked About—But Hard to Execute

by Team Lumida
January 20, 2026
in Macro
Reading Time: 3 mins read
A A
0
Trump Suggests $2,000 Tariff-Funded Payouts to Americans
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key takeaways

Powered by lumidawealth.com

  • European investors hold a massive pool of US assets (over $10T in the EU alone), raising speculation that selling could be used as leverage in the Greenland-linked tariff dispute.
  • In practice, governments have limited control: most holdings sit in private pensions and funds, and forced selling would likely damage European savers as much as US markets.
  • Even discussing “weaponization of capital” signals rising tail risk—turning a trade fight into a potential capital-markets conflict.
  • Markets are already showing a mild “Sell America” reaction (pressure on US assets, support for havens), but strategists see asset dumping as unlikely without further escalation.

What Happened?

As tensions flare over President Trump’s renewed tariff threats tied to Greenland, investors are debating whether Europe could retaliate by selling US bonds and equities. The argument is straightforward: the US relies on foreign capital, so large-scale selling could push US yields higher and weigh on equities. Strategists note, however, that most European-held US assets are owned by private-sector investors rather than governments, limiting policymakers’ ability to act directly.

Why It Matters?

This introduces a new, more consequential risk channel for markets. Trade wars typically hit growth expectations and corporate margins; a “financial war” would directly pressure funding conditions, risk premia, and asset prices through capital flows. Even if the probability is low, the impact could be large: higher Treasury yields would tighten financial conditions, a weaker dollar could follow, and equity multiples could compress—especially if the market starts to question the durability of “US exceptionalism.” For Europe, the constraint is self-inflicted damage: selling US assets at scale would likely hurt European pensions and portfolios and could trigger broader volatility.

What’s Next?

Watch for signs that official Europe is moving from trade countermeasures toward capital-market signaling—such as public-sector funds slowing US purchases, policy rhetoric encouraging “rebalancing” toward euro assets, or incentives favoring domestic capital allocation. The more immediate focus is the escalation path: if tariff threats broaden and retaliation intensifies, the tail risk of capital weaponization rises. For markets, the key indicators are cross-asset stress signals—moves in Treasury yields, the dollar, credit spreads, and haven demand—showing whether “Sell America” remains a short-lived trade or becomes a persistent allocation shift.

Source
Previous Post

a16z Doubles Down on AI Infrastructure With a $3B War Chest—Betting Demand Outruns Bubble Fears

Next Post

The $4.6 Trillion Inheritance Wave Is Rewiring Luxury Real Estate

Recommended For You

Trump’s New Push to Revive Coal Industry with Pentagon Funding

by Team Lumida
24 hours ago
Trump’s New Push to Revive Coal Industry with Pentagon Funding

Key takeaways Powered by lumidawealth.com Trump’s new initiative uses Pentagon contracts and Defense Production Act to sustain U.S. coal-fired plants. $175 million from the Energy Department will fund upgrades...

Read more

Trump’s “Wall Street Homebuyer Ban” Runs Into Congressional Reality

by Team Lumida
2 days ago
aerial photography of rural

Key takeaways Powered by lumidawealth.com The White House is pressing Republicans to add a ban on institutional purchases of single-family homes to major housing bills, but lawmakers are resisting....

Read more

Trump Sets a 15% Growth Bar for Fed Pick Warsh, Raising Independence Stakes

by Team Lumida
2 days ago
Tech Titans Pivot: Silicon Valley’s New Alliance in Trump’s Second Term

Key takeaways Powered by lumidawealth.com Trump said his Fed chair pick Kevin Warsh can drive the economy to 15% growth, an exceptionally high target by historical standards. The comments...

Read more

US Treasury Blames Chinese Speculation for Gold’s Violent Reversal

by Team Lumida
3 days ago
US Treasury Blames Chinese Speculation for Gold’s Violent Reversal

Key takeaways Powered by lumidawealth.com US Treasury Secretary Scott Bessent said speculative trading in China drove extreme volatility in gold prices. Chinese authorities reportedly tightened margin requirements as gold...

Read more

China Quietly Signals Banks to Reduce US Treasury Exposure

by Team Lumida
3 days ago
U.S. Struggles to Break China’s Grip on Critical Minerals as Syrah Resources Faces Setbacks

Key takeaways Powered by lumidawealth.com Chinese regulators have advised domestic banks to limit new purchases of US Treasuries and cut back existing exposure. The guidance reflects concerns over concentration...

Read more

A Chinese Factory Comes to Ohio—and Exposes the Limits of “Onshoring”

by Team Lumida
3 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key takeaways Powered by lumidawealth.com A Chinese automotive-glass maker’s U.S. expansion has undercut domestic competitors, putting hundreds of American manufacturing jobs at risk. The case highlights a policy tension:...

Read more

New START Expires, Leaving US-Russia Nuclear Limits Without a Binding Framework

by Team Lumida
7 days ago
New START Expires, Leaving US-Russia Nuclear Limits Without a Binding Framework

Key takeaways Powered by lumidawealth.com New START has expired, ending the last major US-Russia strategic arms-control agreement and its verification framework. The biggest near-term loss is transparency (inspections/data exchanges),...

Read more

U.S.–China “Economic Divorce” Accelerates as National Security Trumps Free Trade

by Team Lumida
7 days ago
U.S.–China “Economic Divorce” Accelerates as National Security Trumps Free Trade

Key takeaways Powered by lumidawealth.com The U.S. and China are moving toward a managed but messy decoupling focused on strategic sectors: semiconductors, energy, food, and critical minerals. China is...

Read more

U.S. Shutdown Ends, but DHS “Cliff Date” Keeps Policy and Market Risk Alive

by Team Lumida
1 week ago
White House, Washington DC

Key takeaways Powered by lumidawealth.com Donald Trump signed a stopgap funding deal to end the partial shutdown, after a cross-party standoff tied to immigration enforcement. The bill keeps most...

Read more

U.S.–India Trade Reset Slashes Tariffs as Energy Realignment Becomes the Price of Market Access

by Team Lumida
1 week ago
Trump Pushes for Greenland Acquisition, Exploring Business Deals and Military Presence

Key takeaways Powered by lumidawealth.com The U.S. will lower tariffs on Indian goods to 18%, reversing a punitive structure that had reached as high as 50% in total. India...

Read more
Next Post
Climate-Risk Scores Are Now a Hidden “Third Price” in Housing — and Sellers Are Fighting Back

The $4.6 Trillion Inheritance Wave Is Rewiring Luxury Real Estate

Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

the apple logo is reflected in the glass of a building

Apple Dominates: $250 Billion Index Trades Reshape Wall Street

September 20, 2024
Why Investors Are Flocking to Carry Trades Right Now

Why Investors Are Flocking to Carry Trades Right Now

May 24, 2024
AI Boom Propels S&P 500: Will the Momentum Continue?

ASML’s Order Book Surges: A Boon from AI Demand

July 16, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018